Addendum: Alfuzosin (Uroxatral) -- Another Alpha1-blocker for Benign Prostatic Hyperplasia

The Medical Letter on Drugs and Therapeutics

FROM
ISSUE

1173

January 5, 2004

View Complete Issue Table of Contents 2019

Addendum: Alfuzosin (Uroxatral) -- Another Alpha1-blocker for Benign Prostatic Hyperplasia

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 2004 Jan 5;46(1173):4

Disclosures

Objective(s)

SUMMARY: Addendum: The table in the article on alfuzosin for treatment of benign prostatic hyperplasia (January 5, 2004, vol. 46, p.1) omitted the generic alpha₁-blockers. The complete table with prices updated to December 2003 is now in the issue.

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.